Sign Out
Administration while pregnant or lactation: The safety data of the drug in pregnant women has not been enough, so when the drug should be given to pregnant women, make sure that the therapeutic benefits are greater than the risks.
Lactation should be discontinued when the drug is given to nursing mothers. Studies in mice showed Rebamipide could be excreted through breast milk.
Administration in children: Clinical trials and safety data in children has not been enough.
Administration in elderly: Administration in elderly people needs an extra attention to reduce the risk of gastrointestinal tract disorders, because elderly patients are more sensitive to drugs.
